Drugs / HRS-1738
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07056439 | Jul 2025 → Aug 2026 overdue | — | Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRS-1738 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07056439 ↗ |